At a glance
- Originator Metabasis Therapeutics
- Class Neuroprotectants
- Mechanism of Action Adenosine A1 receptor agonists; Adenosine A1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Craniocerebral trauma; Stroke
Most Recent Events
- 02 Jul 2001 No-Development-Reported for Head injuries in USA (Unknown route)
- 02 Jul 2001 No-Development-Reported for Stroke in USA (Unknown route)
- 03 Sep 1998 New profile